Abingdon Health Plc (AIM:ABDX)

Revenue by Segment

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018
Product Sales	534.00K	650.00K	418.00K	465.00K	8.36M
Product Sales Growth	-17.85%	55.50%	-10.11%	-94.44%	1281.82%
Contract Manufacturing	1.27M	1.26M	1.06M	1.12M	1.69M
Contract Manufacturing Growth	0.95%	18.90%	-5.87%	-33.49%	83.10%
Regulatory	3.42M	900.00K	268.00K	-	-
Regulatory Growth	280.00%	235.82%	-	-	-
Contract Development	3.21M	3.33M	2.30M	1.25M	1.57M
Contract Development Growth	-3.67%	44.59%	84.67%	-20.54%	-57.70%
Total	8.43M	6.14M	4.05M	2.84M	11.62M
Total Growth	37.39%	51.67%	42.68%	-75.60%	121.93%

Revenue by Geography

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018
United Kingdom	4.49M	2.54M	1.31M	1.42M	6.60M
United Kingdom Growth	76.83%	94.19%	-7.76%	-78.52%	60.76%
Europe	1.67M	1.24M	-	-	-
Europe Growth	35.55%	-	-	-	-
USA & Canada	2.14M	2.04M	861.00K	182.00K	3.41M
USA & Canada Growth	4.76%	136.82%	373.08%	-94.65%	1219.77%
Rest of The World	131.00K	323.00K	219.00K	164.00K	57.00K
Rest of The World Growth	-59.44%	47.49%	33.54%	187.72%	-16.18%
Europe (excluding Belgium)	-	-	1.18M	334.00K	755.00K
Europe (excluding Belgium) Growth	-	-	252.99%	-55.76%	-
Belgium	-	-	479.00K	738.00K	805.00K
Belgium Growth	-	-	-35.09%	-8.32%	-
Total	8.43M	6.14M	4.05M	2.84M	11.62M
Total Growth	37.39%	51.67%	42.68%	-75.60%	121.93%

Source: S&P Global Market Intelligence.